Advancements in bioinformatics and systems biology have revolutionized our understanding of complex diseases, paving the way ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

Research reveals that the combination of palbociclib and telaglenastat, two drugs with complementary actions, could help ...

Qatar’s 3rd Qatar Proteomics Conference brought together world-renowned academic scientists, researchers and scholars for a ...

When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of Health Sciences during the summer of his first year, he had no research or ...

Emma's brain tumour has stopped growing since she gained access to a type of immunotherapy identified by molecular testing.

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors ...

A University of Alberta research team is shedding much-needed light on cancer cachexia, a severe muscle-wasting syndrome ...

Colorectal cancer is one of the most common tumours among people over the age of 50. Although it is known to develop from ...

Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and ...

When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of Health Sciences ...